↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Germany TED / Vergabe.de contract award · ocds-ted-370542-2026-4

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W

DAK-Gesundheit awarded a contract of undisclosed value to Boehringer Ingelheim Pharma GmbH & Co. KG for Healthcare & Medical in May 2026 — one of 389 awards this buyer has made.

Healthcare & Medical
29 May 2026
Award date
Not disclosed
Contract value

Buying agency

DAK-Gesundheit
389 Awards
€581K Avg award

Winning supplier

Boehringer Ingelheim Pharma GmbH & Co. KG
1 Award
1 Buyer

Contract description

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tiotropium + Olodaterol, ATC R03AL06 für die Zeit 01.06.2024 - 31.05.2026

Premium

Related awards · DAK-Gesundheit

389 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for DAK-Gesundheit and Boehringer Ingelheim Pharma GmbH & Co. KG — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up